GlassScriptPhysician profile
Gary A Ludi
NPI 1235198284
$543.19
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $411 · 2020: $34.29 · 2021: $61.59 · 2024: $35.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $35.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $35.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $149.36 | 2019 | |
| Stryker Corporation | $125.00 | 2019 | |
| Davol INC. | $42.13 | 2019 | |
| Aroa Biosurgery Incorporated | $35.96 | 2024 | |
| Integra Lifesciences Corporation | $34.71 | 2021 | |
| Innocoll Pharmaceuticals Limited | $26.88 | 2021 | |
| Acera Surgical, INC. | $22.66 | 2019 | |
| Prescient Surgical | $19.83 | 2020 | |
| Abbott Laboratories | $19.28 | 2019 | |
| Focal Therapeutics, INC. | $15.97 | 2019 | |
| Teleflex LLC | $14.46 | 2020 | |
| Acell, INC. | $13.51 | 2019 | |
| Covidien LP | $12.38 | 2019 | |
| Merck Sharp & Dohme LLC | $11.06 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Ludi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.